Personal information

Other IDs

Scopus Author ID: 57191370097
Loop profile: 1306726

Activities

Collapse all

Employment (3)

Boehringer Ingelheim RCV GmbH und Co KG: Wien, Wien, AT

2021-09-01 to present
Employment
Source: Self-asserted source
Hussein Al-Akhrass

Turku Bioscience Centre and FICAN West Cancer Center, University of Turku and Åbo Akademi University: Turku, FI

2018-03-01 to present | Postdoctoral researcher (Cell Adhesion and Cancer Laboratory)
Employment
Source: Self-asserted source
Hussein Al-Akhrass

EA3842 Cellular Homeostasis and Pathologies: Limoges, FR

2014-10-01 to present (Haute-Vienne)
Employment
Source: Self-asserted source
Hussein Al-Akhrass

Education and qualifications (1)

Université de Limoges Faculté de Médecine: Limoges, FR

2014-10-01 to present
Education
Source: Self-asserted source
Hussein Al-Akhrass

Works (10)

Publisher Correction: Cargo-specific recruitment in clathrin- and dynamin-independent endocytosis

Nature Cell Biology
2022-09 | Journal article
DOI: 10.1038/s41556-022-00952-6
Contributors: Paulina Moreno-Layseca; Niklas Z. Jäntti; Rashmi Godbole; Christian Sommer; Guillaume Jacquemet; Hussein Al-Akhrass; James R. W. Conway; Pauliina Kronqvist; Roosa E. Kallionpää; Leticia Oliveira-Ferrer et al.
Source: check_circle
Crossref

Cargo-specific recruitment in clathrin- and dynamin-independent endocytosis

Nature Cell Biology
2021-10 | Journal article
DOI: 10.1038/s41556-021-00767-x
Contributors: Paulina Moreno-Layseca; Niklas Z. Jäntti; Rashmi Godbole; Christian Sommer; Guillaume Jacquemet; Hussein Al-Akhrass; James R. W. Conway; Pauliina Kronqvist; Roosa E. Kallionpää; Leticia Oliveira-Ferrer et al.
Source: check_circle
Crossref

The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer

Cancers
2021-06-11 | Journal article
DOI: 10.3390/cancers13122916
Contributors: Hussein Al-Akhrass; Niki Christou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Sortilin-related receptor is a druggable therapeutic target in breast cancer

2021-03-09 | Preprint
DOI: 10.1101/2021.03.09.434556
Contributors: Hussein Al-Akhrass; Mika Pietilä; Johanna Lilja; Ella-Maria Vesilahti; Johanna M. Anttila; Heidi M. Haikala; Pauliina M. Munne; Juha Klefström; Emilia Peuhu; Johanna Ivaska
Source: check_circle
Crossref

A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance

Oncogene
2021-02-18 | Journal article
DOI: 10.1038/s41388-020-01604-5
Contributors: Hussein Al-Akhrass; James R. W. Conway; Annemarie Svane Aavild Poulsen; Ilkka Paatero; Jasmin Kaivola; Artur Padzik; Olav M. Andersen; Johanna Ivaska
Source: check_circle
Crossref

A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance

2020-06-10 | Preprint
DOI: 10.1101/2020.06.10.143735
Contributors: Hussein Al-Akhrass; James R.W. Conway; Annemarie Svane Aavild Poulsen; Ilkka Paatero; Jasmin Kaivola; Artur Padzik; Olav M. Andersen; Johanna Ivaska
Source: check_circle
Crossref

SORLA regulates endosomal trafficking and oncogenic fitness of HER2.

Nature communications
2019-05-28 | Journal article
DOI: 10.1038/s41467-019-10275-0
PMID: 31138794
PMC: PMC6538630
Source: Self-asserted source
Hussein Al-Akhrass

Sortilin limits EGFR signaling by promoting its internalization in lung cancer.

Nature communications
2017-10-30 | Journal article
DOI: 10.1038/s41467-017-01172-5
PMID: 29084952
PMC: PMC5662760
Source: Self-asserted source
Hussein Al-Akhrass

A new role under sortilin’s belt in cancer

Communicative and Integrative Biology
2016 | Journal article
DOI: 10.1080/19420889.2015.1130192
EID:

2-s2.0-84960884836
Contributors: Wilson, C.M.; Naves, T.; Akhrass, H.A.; Vincent, F.; Melloni, B.; Bonnaud, F.; Lalloué, F.; Jauberteau, M.-O.
Source: Self-asserted source
Hussein Al-Akhrass via Scopus - Elsevier

Challenges and strategies in precision medicine for non-small-cell lung cancer

Current Pharmaceutical Design
2016 | Journal article
DOI: 10.2174/1381612822666160603014932
EID:

2-s2.0-84989244702
Contributors: Sacco, J.J.; Al-Akhrass, H.; Wilson, C.M.
Source: Self-asserted source
Hussein Al-Akhrass via Scopus - Elsevier
How many people are using ORCID?